• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

克罗恩病肠外瘘的内镜治疗。

Endoscopic Treatment of Enterocutaneous Fistulas in Crohn's Disease.

机构信息

Department of Gastroenterology, Amiens University hospital, Picardie University, Amiens, France.

Department of Digestive Surgery, Amiens University hospital, Picardie University, Amiens, France.

出版信息

Dis Colon Rectum. 2022 May 1;65(5):721-726. doi: 10.1097/DCR.0000000000001995.

DOI:10.1097/DCR.0000000000001995
PMID:33990501
Abstract

BACKGROUND

Management of enterocutaneous fistulas in Crohn's disease is challenging. Most patients still need intestinal resection in the biologic era.

OBJECTIVE

The aim of this study was to evaluate the efficacy of endoscopic treatment for enterocutaneous fistulas.

DESIGN

This is a retrospective study of medical records.

SETTINGS

This study was conducted in a single institution.

PATIENTS

All consecutive patients with Crohn's disease with an enterocutaneous fistula who underwent endoscopic fistula closure with the use of an over-the-scope clip or a hemostatic clip were included.

MAIN OUTCOME MEASURES

The main outcome measured was the clinical success 3 months after the procedure, which was defined as the complete closure of all fistulas at physical examination and complete cessation of the drainage from the external opening, without surgery.

RESULTS

Eight patients (men, 25%; median age 45 years [interquartile range, 33-51]) were followed. Fistulas were localized at the ileocolonic or colocolonic anastomosis in 7 patients and at the stomach in 1 patient. Seven patients were treated with an over-the-scope clip, and one was treated with a hemostatic clip. Technical success was achieved in all cases. Clinical success at 3 months was achieved in 75% of cases (6/8 patients). After a median 16-month (interquartile range, 13-23) follow-up, 3 of 8 (37.5%) patients had enterocutaneous fistula closure and 2 of 8 (25%) needed intestinal resection. No complications were observed.

LIMITATIONS

The retrospective nature, the small sample size of the study, and the heterogeneity of the population limit the interpretation of the results.

CONCLUSIONS

Endoscopic treatment of enterocutaneous fistulas is feasible with a short-term effectiveness. Additional studies are needed to confirm these results. See Video Abstract at http://links.lww.com/DCR/B614.

TRATAMIENTO ENDOSCPICO DE FSTULAS ENTEROCUTNEAS EN ENFERMEDAD DE CROHN

ANTECEDENTES:Es desafiante el manejo de las fístulas enterocutáneas en enfermedad de Crohn. En la era biológica, la mayoría de los pacientes todavía requieren de resección intestinal.OBJETIVO:Evaluar la eficacia por tratamiento endoscópico de fístulas enterocutáneas.ENTORNO CLINICO:Estudio retrospectivo de registros médicos.AJUSTE:Realizado en una sola institución.PACIENTES:Se incluyeron todos los pacientes consecutivos con fístula enterocutánea en enfermedad de Crohn, sometidos a cierre endoscópico de la fístula con clip sobre el endoscopio o clip hemostático.PRINCIPALES MEDIDAS DE VALORACION:El éxito clínico a los 3 meses después del procedimiento. Definido al examen físico, como el cierre completo de todas las fístulas y cese completo del drenaje por la abertura externa, sin cirugía.RESULTADOS:Se estudiaron a ocho pacientes (hombres, 25%, mediana de edad de 45 años (rango intercuartílico, 33-51)). En 7 pacientes, las fístulas se localizaron en la anastomosis ileocolónica o colocolónica y un paciente, en el estómago. Siete pacientes fueron tratados con clip sobre el endoscopio y uno con clip hemostático. Se logró éxito técnico en todos los casos. Se logró éxito clínico a los 3 meses en 75% de los casos (6/8 pacientes). Después de una mediana de 16 meses (rango intercuartílico, 13-23), de seguimiento 3/8 (37,5%) pacientes presentaron cierre de fístulas enterocutáneas y 2/8 (25%) requirieron resección intestinal. No se observaron complicaciones.LIMITACIONES:Estudio retrospectivo, pequeño tamaño de la muestra y heterogeneidad de la población, limitaron la interpretación de los resultados.CONCLUSIONES:Es posible el tratamiento endoscópico de fístulas enterocutáneas con efectividad a corto plazo. Se requieren nuevos estudios para confirmar estos resultados. Consulte Video Resumen en http://links.lww.com/DCR/B614. (Traducción-Dr. Fidel Ruiz Healy).

摘要

背景

克罗恩病的肠皮瘘的管理具有挑战性。在生物时代,大多数患者仍需要肠道切除术。

目的

本研究旨在评估内镜治疗肠皮瘘的疗效。

设计

这是一项回顾性病历研究。

设置

本研究在一家单机构进行。

患者

所有连续的患有克罗恩病并伴有肠皮瘘的患者,均接受过内镜下瘘口闭合治疗,使用过内镜下夹子或止血夹。

主要观察指标

主要观察指标是术后 3 个月的临床成功率,定义为体检时所有瘘口完全闭合,外部开口引流完全停止,无需手术。

结果

共纳入 8 例(男性 25%;中位年龄 45 岁[四分位距 33-51])患者。7 例患者的瘘口位于回肠结肠或结肠直肠吻合口,1 例患者位于胃。7 例患者接受内镜下夹子治疗,1 例患者接受止血夹治疗。所有病例均达到技术成功。75%(6/8 例)的患者在 3 个月时达到临床成功。在中位 16 个月(四分位距 13-23)的随访后,8 例患者中有 3 例(37.5%)肠皮瘘闭合,2 例(25%)需要肠道切除术。无并发症发生。

局限性

研究的回顾性、样本量小以及人群异质性限制了结果的解释。

结论

内镜治疗肠皮瘘是可行的,具有短期疗效。需要进一步的研究来证实这些结果。查看视频摘要请点击 http://links.lww.com/DCR/B614。

相似文献

1
Endoscopic Treatment of Enterocutaneous Fistulas in Crohn's Disease.克罗恩病肠外瘘的内镜治疗。
Dis Colon Rectum. 2022 May 1;65(5):721-726. doi: 10.1097/DCR.0000000000001995.
2
Surgical Techniques and Differences in Postoperative Outcomes for Patients With Crohn's Disease With Ileosigmoid Fistulas: A Single-Institution Experience, 2010-2016.克罗恩病合并回肠-乙状结肠瘘患者的手术技术及术后结局差异:2010-2016 年单中心经验
Dis Colon Rectum. 2019 Oct;62(10):1222-1230. doi: 10.1097/DCR.0000000000001451.
3
Long-term Outcomes of Perianal Fistulas in Pediatric Crohn's Disease.儿童克罗恩病肛周瘘管的长期结局。
Dis Colon Rectum. 2023 Jun 1;66(6):816-822. doi: 10.1097/DCR.0000000000002690. Epub 2023 Mar 1.
4
A Prospective, Single-Arm Study to Evaluate the Safety and Efficacy of an Autologous Blood Clot Product in the Treatment of Anal Fistula.一项评估自体血凝块产品治疗肛瘘安全性和有效性的前瞻性单臂研究。
Dis Colon Rectum. 2024 Apr 1;67(4):541-548. doi: 10.1097/DCR.0000000000003190. Epub 2023 Dec 27.
5
Gracilis Flap Repair for Reoperative Rectovaginal Fistula.股薄肌皮瓣修复复发性直肠阴道瘘
Dis Colon Rectum. 2023 Jan 1;66(1):113-117. doi: 10.1097/DCR.0000000000002249. Epub 2022 Oct 25.
6
Endoscopic Vacuum Therapy for Left-Sided Colorectal Anastomotic Leak Without Fecal Diversion.内镜下真空治疗术在不进行粪便转流的情况下治疗左侧结直肠吻合口漏。
Dis Colon Rectum. 2022 Mar 1;65(3):421-428. doi: 10.1097/DCR.0000000000001959.
7
Follow-up Study to Evaluate the Long-term Safety and Efficacy of Darvadstrocel (Mesenchymal Stem Cell Treatment) in Patients With Perianal Fistulizing Crohn's Disease: ADMIRE-CD Phase 3 Randomized Controlled Trial.评估达伐司特罗细胞(间充质干细胞治疗)治疗肛周瘘管型克罗恩病患者的长期安全性和疗效的随访研究:ADMIRE-CD 期 3 随机对照试验。
Dis Colon Rectum. 2022 May 1;65(5):713-720. doi: 10.1097/DCR.0000000000002325.
8
Use of Darvadstrocel (Allogenic Stem Cell Therapy) for Crohn's Fistulas in Real Clinical Practice: The National Project to Implement Mesenchymal Stem Cell for the Treatment of Perianal Crohn's Fistula (the PRIME Study).达伐司特罗细胞(同种异体干细胞治疗)在克罗恩病瘘管中的真实临床应用:全国实施间充质干细胞治疗肛周克罗恩病瘘管的项目(PRIME 研究)。
Dis Colon Rectum. 2024 Jul 1;67(7):960-967. doi: 10.1097/DCR.0000000000003216. Epub 2024 Apr 11.
9
Efficacy and Safety of Treatment of Complex Idiopathic Fistula-in-Ano Using Autologous Centrifuged Adipose Tissue Containing Progenitor Cells: A Randomized Controlled Trial.采用含祖细胞的自体离心脂肪组织治疗复杂特发性肛瘘的疗效和安全性:一项随机对照试验。
Dis Colon Rectum. 2021 Oct 1;64(10):1276-1285. doi: 10.1097/DCR.0000000000001924.
10
Colonic Wall Injuries After Endoscopic Resection: Still a Major Complication? A Retrospective Analysis of 3782 Endoscopic Resections.内镜切除术后的结肠壁损伤:仍是主要并发症吗?对3782例内镜切除术的回顾性分析
Dis Colon Rectum. 2022 Apr 1;65(4):581-589. doi: 10.1097/DCR.0000000000001974.

引用本文的文献

1
[Not Available].[无可用内容]。
Tunis Med. 2024 Apr 5;102(4):181-188. doi: 10.62438/tunismed.v102i4.4699.
2
Timing of individualized surgical intervention in Crohn's disease.克罗恩病个体化手术干预的时机
World J Gastrointest Surg. 2022 Dec 27;14(12):1320-1328. doi: 10.4240/wjgs.v14.i12.1320.
3
Managing complex perianal disease after anti-TNF failure: Where to go next?抗TNF治疗失败后复杂肛周疾病的管理:下一步何去何从?
Curr Res Pharmacol Drug Discov. 2022 Jan 13;3:100081. doi: 10.1016/j.crphar.2022.100081. eCollection 2022.